AmeriFlex Group’s Serina Therapeutics SER Stock Holding History

AmeriFlex Group’s Portfolio SER Stock Details SER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2	Closed	-$11	–	1299
2025 Q1	$11	Hold	2	–	–	﹤0.01%	1270
2024 Q4	$9	Buy	+2	New	+$12	﹤0.01%	1154

Other funds holding SER

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

Waverly Advisors Birmingham, Alabama $13.4B AUM 18.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

AmeriFlex Group's SER Position: Q2 2025 in Review

AmeriFlex Group sold out of Serina Therapeutics (SER) in Q2 2025, closing a stake of 2 shares — an estimated $11 sold.

AmeriFlex Group first reported a position in SER in Q4 2024 and held it in 2 quarters. The position peaked at $11 in Q1 2025. 23 funds tracked by Wall St. Rank hold SER as of Q2 2025.

AmeriFlex Group reported no remaining Serina Therapeutics position as of Q2 2025 after selling out during the quarter.
AmeriFlex Group sold 2 Serina Therapeutics shares in Q2 2025, an estimated $11.
AmeriFlex Group first reported a position in Serina Therapeutics in Q4 2024 and held it in 2 quarters.
AmeriFlex Group's Serina Therapeutics position peaked at $11 in Q1 2025.
23 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2025.

Based on AmeriFlex Group's 13F filing for Q2 2025, filed 21 Jul 2025.